Share Email Print
cover

Proceedings Paper

Evaluation of contrast and intratumoral heterogeneity for ABY-029 in glioma, with pre-doses of unlabeled cetuximab as a receptor 'cold dose'
Author(s): Ana Luiza Ribeiro de Souza; Kayla A. Marra; Clare Snyder; Jason R. Gunn; Kimberley S. Samkoe; Keith D. Paulsen; Joachim Feldwisch; Brian W. Pogue
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Details

Date Published:
PDF
Proc. SPIE 10049, Molecular-Guided Surgery: Molecules, Devices, and Applications III, 100490Q; doi: 10.1117/12.2252763
Show Author Affiliations
Ana Luiza Ribeiro de Souza, Thayer School of Engineering at Dartmouth (United States)
CAPES Foundation, Ministry of Education of Brazil (Brazil)
Kayla A. Marra, Thayer School of Engineering at Dartmouth (United States)
Clare Snyder, Thayer School of Engineering at Dartmouth (United States)
Jason R. Gunn, Thayer School of Engineering at Dartmouth (United States)
Kimberley S. Samkoe, Geisel School of Medicine (United States)
Thayer School of Engineering at Dartmouth (United States)
Keith D. Paulsen, Thayer School of Engineering at Dartmouth (United States)
Geisel School of Medicine, Dartmouth College (United States)
Joachim Feldwisch, Affibody AB (Sweden)
Brian W. Pogue, Thayer School of Engineering at Dartmouth (United States)
Geisel School of Medicine, Dartmouth College (United States)


Published in SPIE Proceedings Vol. 10049:
Molecular-Guided Surgery: Molecules, Devices, and Applications III
Brian W. Pogue; Sylvain Gioux, Editor(s)

© SPIE. Terms of Use
Back to Top